NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000032493

Registered date:01/06/2018

Whole-genome sequencing and comprehensive variant analysis of combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCC

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedhepatocellular carcinoma
Date of first enrollment2018/06/01
Target sample size600
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeThe relation between the genomic mutation and the clinicopathological features in combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCC
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaCases in which written informed consent was not obtained

Related Information

Contact

public contact
Name Hiroshi Kawamoto
Address Shogoinkawaharacho 54, Sakyo-ku, Kyoto Japan
Telephone 075-751-3242
E-mail hrkawamoto@kuhp.kyoto-u.ac.jp
Affiliation Graduate School of Medicine, Kyoto University Department of Surgery (Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery)
scientific contact
Name Takamichi Ishii
Address Shogoinkawaharacho 54, Sakyo-ku, Kyoto Japan
Telephone 075-751-3242
E-mail taishii@kuhp.kyoto-u.ac.jp
Affiliation Graduate School of Medicine, Kyoto University Department of Surgery (Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery)